(taurolidine and heparin) catheter lock solution

DRUG2 trials

Sponsors

CorMedix Therapeutics

Conditions

Catheter-Related InfectionsCentral Line Associated Blood Stream Infections (CLABSI)

Phase 3

Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)

RecruitingNCT06822426

CorMedix TherapeuticsCentral Line Associated Blood Stream Infections (CLABSI)

Start: 2025-05-14End: 2028-01-01Target: 200Updated: 2026-08-05

Phase 4

Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age

RecruitingNCT06714864

CorMedix TherapeuticsCatheter-Related Infections

Start: 2025-07-08End: 2029-04-01Target: 36Updated: 2026-08-05